还没做过化疗，EGFR是野生型的病友一定要去做ALK的检测

jzjqian 发表于 2012-7-25 15:45

                               
登录/注册后可看大图

请教，像我这样的，手术22个月了，还能去原手术医院拿到病理作EGFR检查么？

1 c" W5 }! G/ Z3 w; }# ^可以，但要有针对性，

请问，肺鳞癌，只做过一次化疗，骨髓抑制严重，后吃特罗凯4个月基本无效，可以参加实验组吗？

不可以了,要没做过任何治疗的,包括化疗和靶向药

Concomitant EGFR mutation and EML4-ALK gene fusion in non-small cell lung cancer.  Print this page  
- t& t& P) R$ Z: v: m( Z
7 T# [; t3 [3 [- B1 |
" Y5 i  A* k3 D6 d4 VSub-category:
Molecular Targets

: `/ Y; u$ P7 L0 ^* O/ J
Category:
Tumor Biology

3 v+ T. T+ \3 A% j& S- |
Meeting:
% }9 C; r0 h- s' l* D5 X% w% o2011 ASCO Annual Meeting
$ B. D( q9 L: M0 P* D8 I. M& l2 j5 f
  m# {" x" A8 t& f
. h9 {* b" b' ]) ?8 C6 w; G% RSession Type and Session Title:
Poster Discussion Session, Tumor Biology
4 a. a# U7 i- w. E/ G. \

Abstract No:
# o4 t! b1 a! @6 u: U6 Z10517
/ J, r% A" ^' q! U
" |; Q  m# y/ t4 {2 {1 G
Citation:
J Clin Oncol 29: 2011 (suppl; abstr 10517)


- w1 z4 L& l$ R/ n, V# }6 w: @Author(s):
  W* E( I1 Z' p# W# qJ. Yang, X. Zhang, J. Su, H. Chen, H. Tian, Y. Huang, C. Xu, Y. L. Wu; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China; Guangdong Lung Cancer Institute, Medical Research Center of Guangdong General Hospital, Guangzhou, China; Guangdong Lung Cancer Institute, Guangzhou, China; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China

$ c' ]8 p5 P, v. {; z8 q6 }

Abstracts that were granted an exception in accordance with ASCO's Conflict of Interest Policy are designated with a caret symbol (^) here and in the printed Proceedings.
; |5 {* c, j* w% B& R6 s
Abstract Disclosures
2 K4 i3 H% D/ w3 g. }0 M9 B- Q
Abstract:
, Q/ z% Z+ i) I4 B3 ]6 ^' |1 Y

  h! B$ v* D7 U- g- y. @Background: The fusion of the anaplastic lymphoma kinase (ALK) with the echinoderm microtubule-associated protein-like 4 (EML4) and epidermal growth factor receptor (EGFR) mutations are considered mutually exclusive. Advanced non-small cell lung cancer (NSCLC) patients with EML4-ALK did not benefit from EGFR tyrosine kinase inhibitors (TKIs). Methods: Multiplex reverse transcriptase-polymerase chain reaction (RT-PCR) followed by sequencing was performed for EML4-ALK fusion status detection. EGFR and KRAS mutations were determined by direct DNA sequencing. Positive results of EML4-ALK fusion were also confirmed by RACE-coupled PCR sequencing. Results: From April 2010 to January 2011, 412 patients (398 with NSCLC; 14 with SCLC) were tested for mutation status of EGFR, KRAS and EML4-ALK respectively. Frequency of EML4-ALK fusion was 10.6% (42/398) in NSCLC patients. No patients with SCLC were found to have positive EML4-ALK fusion. Frequency of concomitant EGFR and EML4-ALK gene mutations was 1.0% (4/398) in NSCLC patients, and their variants of EML4-ALK gene mutations were Variant 1 (3 patients) and Variant 6 (1 patient); being never smokers, all of them were diagnosed with advanced (3 with stage †W and 1 with stage IIIB) adenocarcinoma harbouring wild type KRAS. Two female stage †W patients with double gene mutations (1 with L858R and Variant 1; 1 with exon19 deletion and Variant 6) received first-line gefitinib which is one kind of EGFR TKIs and achieved partial response. Conclusions: Though being rare events, NSCLC patients harbouring concomitant EGFR mutation and EML4-ALK gene fusion are sensitive to first-line EGFR TKIs. Whether they could also benefit from ALK inhibition after failure to EGFR TKIs warranted further investigation.
$ w3 I# I: ^+ H# F. l' Z* k: e
% F) U, f; a6 M* ~+ Y3 H
$ S8 m2 R& S  q2 a. d

由吴一龙教授牵头的A80810029临床试验上周启动，初诊未治疗的晚期肺腺癌患者检测到ALK阳性，可参加一线crizotinib 对比力比泰+卡铂的临床研究，药物全部免费，即使分配到力比泰组，疾病进展之后可免费获得crizotinib.

没有手术，只化疗过，现吃靶向药，未突变，alk未测，有机会入组吗？

boeun 发表于 2012-11-18 16:37

; `; Y9 F+ k- \- K) U5 h; p                               
登录/注册后可看大图

* C! ]& L+ Y0 F9 ~. ^2 ]: I( |没有手术，只化疗过，现吃靶向药，未突变，alk未测，有机会入组吗？

化疗过的没机会了

平安！ 发表于 2012-7-20 11:20

5 g0 r- n3 ], ~                               
登录/注册后可看大图

易瑞沙、特罗凯有效的病人基本上可以断定ALK（-）。极其罕见EGFR、ALK同时突变的。
% f) t  a% |$ o) `# H7 g3 FALK一个指标医院要900多 ...

+ g/ C: o# V% f2 Z( d平安，真的没有希望吗？我弟弟虽然特罗凯有效，但是ＥＧＦＲ是野生型，不是突变啊。有没有必要去检测ＡＬＫ呢？
) d7 U; W1 ^8 O+ ~( N) d
现在病情进展，快没招儿了。

好像想加入挺困难的

小地方没条件做啊